Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palladian Partners is a health and science communications company focused on strategic communications, digital experience design, creative services, science writing, conference support, and related professional services for government agencies, public health organizations, and mission-driven health clients. The company is not a drug developer; instead, it helps clients design and execute evidence-based public health and healthcare communications campaigns. Its work has included large-scale programs with organizations such as the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention, the National Institutes of Health, and the Office of the Surgeon General. Palladian was acquired by Altarum in 2011 and continues to operate as an active business unit within the Altarum enterprise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palladian Partners.